Available to sourceHuman Prescription DrugGastrointestinal

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE (sodium sulfate, potassium sulfate, magnesium sulfate)

Active ingredients · Magnesium Sulfate Unspecified Form, Potassium Sulfate, Sodium Sulfate

1.6 g/mL / 3.13 g/mL / 17.5 g/mL · Solution Concentrate

By Wilshire Pharmaceuticals, Inc.

NDC: 52536-175
Route: Oral
Therapeutic class: Calculi Dissolution Agent , Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: NDA

Package sizes

2 BOTTLE, PLASTIC in 1 CARTON (52536-175-01) / 177.4 mL in 1 BOTTLE, PLASTICNDC 52536-175-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.